Endocrine Regulations (Jan 2023)

Comparison of aspartate aminotransferase platelet ratio index score and insulin resistance in type 2 diabetes mellitus with non-alcoholic fatty liver disease

  • Gupta Nikhil,
  • Ramzaan Dar Waseem,
  • Wani Asma,
  • Raj Saxena Rachit,
  • Khatri Sahil,
  • Tyagi Bhumesh,
  • Bansal Pankaj,
  • Ahmad Mir Irfan

DOI
https://doi.org/10.2478/enr-2023-0013
Journal volume & issue
Vol. 57, no. 1
pp. 106 – 113

Abstract

Read online

Objective. Nonalcoholic fatty liver disease (NAFLD) is a spectrum of liver diseases characterized by the presence of ectopic fat in the liver and steatosis, which cannot be explained by alcohol consumption. The association between NAFLD and type 2 diabetes mellitus (T2DM) is well established. As liver fibrosis progresses in a patient with NAFLD, insulin resistance (IR) increases and may worsen diabetes control. The aspartate aminotransferase platelet ratio index (APRI) score is a simple and inexpensive bedside marker that can detect liver fibrosis and cirrhosis. Several studies have shown an association between APRI and NAFLD. However, there is a gap in correlation with IR in patients with diabetes. In this study, we sought to correlate IR and NAFLD in diabetes using the APRI score.

Keywords